Nicotine Addiction
56
10
13
35
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
22 trials with published results (39%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
5.4%
3 terminated out of 56 trials
92.1%
+5.6% vs benchmark
18%
10 trials in Phase 3/4
63%
22 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 35 completed trials
Clinical Trials (56)
Acute Pharmacokinetic and Pharmacodynamic Effects of "Tobacco-Free" Oral Nicotine Pouches in Smokers
CONNECT Cancer Survivors With Tobacco Treatment
Evaluation of a Smoking Cessation Program for Long-Term Abstinence
Non-Invasive Deep Brain Neuromodulation for Smoking Cessation
Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community
Semaglutide for Smoking Cessation in Patients With Diabetes
Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy
Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder
Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches
Sex Differences in E-cig Perception: Study 1
Developing Evidence to Inform Regulatory Policy on Nicotine Content in E-Liquids
Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
Effects of Semaglutide on Nicotine Intake
Assess the Influence of Nicotine Flux and Nicotine Form on Subjective Effects Related to Dependency
A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults
Quit Smoking Study for People Who Use E-Cigarettes
Neural Mechanisms Associated With Risk of Smoking Relapse
Nicotine's Effect on Cancer Stem Cell Markers in Human Umbilical Cord Tissue
Electronic Cigarettes as a Harm Reduction Strategy Among People Living With HIV/AIDS
Effectiveness of N-Acetylcysteine (NAC) in Motivational Enhancement Therapy for Nicotine Addiction